{"nct_id":"NCT03301220","title":"A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2017-11-07","start_date_type":"ACTUAL","primary_completion_date":"2024-05-01","primary_completion_date_type":"ACTUAL","completion_date":"2026-01-05","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["JNJ"]}